Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Eli Lilly stock is up on Tuesday as investors in LLY celebrate an FDA panel putting its support behind the company's Alzheimer's drug.

The post Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”